September 01, 2021

Looking Ahead to Factors Shaping Market Activity

A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic. 

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

Senior Vice President, Finance & Treasury

651.632.4009

[email protected]

You may also like:

The Importance of Maintaining DE&I Activities to Drive Continued Innovation & Resilience

CHRO Deb LaMere explains why it's important to continue to invest in DE&I even when the financial outlook seems uncertain.

Nasdaq
CFOs’ Most Important Role: Top Communicator

CFO Tom Donnelly discusses communicating, goals and investment priorities in 2023.

Future-Proof Customer Experience With Investments in Support and Service

Chief Customer Success Officer Deven Lindemann comments on how and where to invest in the customer experience.

CMS Wire logo